| Ytd | -72.13% | |
| 1y | -80.25% |
| Open | 0.81 | Prev Close | 0.80 | Low | 0.77 | High | 0.81 | Mkt Cap | 84.42M |
| Vol | 3.57K | Avg Vol | 381.65K | EPS | -1.67 | P/E | N/A | Forward P/E | 13.42 |
| Beta | 1.33 | Short Ratio | 4.71 | Inst. Own | 95.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.88 | 200-d Avg | 1.95 | 1yr Est | 5.25 |
B of A Securities analyst Allen Lutz downgrades Definitive Healthcare (NASDAQ:DH) from Buy to Und
Customer success leader joins executive team to help restaurant operators accelerate value realizati
Latest enhancements provide deeper medical claims insights, a new integration with HubSpot®, seamles
Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, beating the Za
FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthc
Definitive Healthcare (DH) doesn't possess the right combination of the two key ingredients for a li
FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healt
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and l
Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term p
Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript
Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and
Stephens & Co. analyst Jeff Garro maintains Definitive Healthcare (NASDAQ:DH) with a Equal-We
Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has earned an average recommendation of "
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, in line with t
Definitive Healthcare (NASDAQ:DH) is looking for FY2026 Adj EPS of $0.14-$0.17 vs $0.26 analyst esti
Definitive Healthcare (NASDAQ:DH) is looking for Q1 Adj EPS of $0.03 vs $0.06 analyst estimate. sees
Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.06 per share which met the analy
FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Health
Definitive Healthcare (NASDAQ: DH - Get Free Report) will likely be issuing its Q4 2025 results afte
Shares of Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) have been given a consensus rec
FRAMINGHAM, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Health
FRAMINGHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and l
Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and
Definitive Healthcare Corp. ( DH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Partic
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.07 per share, beating the Za
Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.22-$0.23 to $0.23-$0.24 vs
Definitive Healthcare (NASDAQ:DH) is looking for Q4 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate
Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the anal
FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Health
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Health
Stifel analyst David Grossman maintains Definitive Healthcare (NASDAQ:DH) with a Buy and raises t
Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.20-$0.23 to $0.22-$0.23 vs
Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate
Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the anal
Goldman Sachs analyst Kash Rangan maintains Definitive Healthcare (NASDAQ:DH) with a Neutral and
Full Year 2025: Revenue is expected to be in the range of $234.0 – $240.0 million, raising the bott
Second Quarter 2025: Revenue is expected to be in the range of $58.5 – $60.0 million. Adjusted Oper